Exclusive: Pfizer weighs sale or spin-off of consumer health unit - sources

(Reuters) - U.S. drugmaker Pfizer Inc is evaluating a potential sale or spin-off of its consumer health division that could value the unit at as much as $14 billion, people familiar with the matter said on Wednesday.

Exclusive: Pfizer weighs sale or spin-off of consumer health unit - sources
Read More


Bagikan Berita Ini